BioAscent Discovery

Opportunity knocks: why high quality leads matter

3 September 2020

Does every cloud have a silver lining? Dr Phil Jones, Chief Scientific Officer, BioAscent Discovery outlines the opportunities for lead generation and the acquisition of compound screening libraries. The discovery of novel medicines is a complex but vital endeavour. The range of approaches being used to identify those new medicines is ever widening with, for […]